Check out your Company Bowl for anonymous work chats.
FUJIFILM Diosynth Biotechnologies has facilities in communities in California, Massachusetts, North Carolina, Texas as well as Denmark and the United Kingdom. We strive to be a good community partner and maintain the highest reputation as a leading employer in the areas where we are located. We seek opportunities to promote careers in science with local schools, colleges, and universities and we conduct coordinated efforts to help raise funds and awareness for people and causes around the world who are aligned with our core purpose – Partners for Life, Advancing Tomorrow’s Medicines. Each FDB site is located in a community with a unique culture and heritage – we encourage team members to take part in the cultural activities and important community initiatives that excite them. This fuels their Genki and creativity and enhances our collective strength.
Lars Petersen, Global President & Chief Executive Officer of FDB. Lars is a visionary leader with over 30 years of experience in Life Science including his tenure at FUJIFILM Diosynth Biotechnologies. In 2019 when FUJIFILM Diosynth Biotechnologies acquired the Biogen site in Hillerød, Denmark, he assumed the role of COO for the site, and he most recently served as the Head of the Large-Scale business unit in charge of manufacturing sites in Denmark and Holly Springs, North Carolina, US. Lars has been responsible for the Global Large Scale Commercial operation including full profit and loss accountability as well as the responsibility for over $6.2 Billion global expansions both in Hillerød, Denmark, and Holly Springs, NC. Lars has held leadership positions with Biogen, Genentech/Roche, Novo Nordisk, Novozymes and NNE, and he has successfully executed projects in Europe, China and the US. Lars holds a master's degree from the Technical University of Denmark.